Intraosseous Infusion Devices Market Introduction and Overview
According to SPER Market Research, the Global Intraosseous Infusion Devices Market is estimated to reach USD 8.74 billion by 2033 with a CAGR of 7.11%.
The report includes an in-depth analysis of the Global Intraosseous Infusion Devices Market, including market size and trends, product mix, applications, and supplier analysis. Medical equipment known as intraosseous (IO) infusion devices are used to administer fluids, drugs, and other therapies straight into the bone marrow in situations when traditional intravenous (IV) access is challenging or impossible, such as in patients with collapsed veins or during emergencies. An efficient and dependable method of fluid resuscitation is established by inserting the IO device into the tibia, femur, or other accessible bones. Because to its great vascularization, the bone marrow facilitates quick absorption into the bloodstream. These tools are frequently utilized in pediatric care, trauma, and resuscitation procedures when prompt access to blood flow is essential.
Market Opportunities and Challenges
Opportunities- The global market for intraosseous infusion devices is growing gradually, mostly due to a rise in emergency medical cases and a high prevalence of chronic illnesses, both of which raise the risk of hospitalization. Additionally, the market is growing as a result of substantial government investments in technology that facilitate simple and quick drug administration, as well as greater physician and patient awareness of recently developed therapeutic processes and technologies. Furthermore, sedentary lifestyles have a detrimental effect on human health and raise the risk of a number of conditions, including diabetes, cardiovascular disease, end-stage renal disease, chronic obstructive pulmonary disease, urological problems, and other chronic illnesses. With intraosseous devices, the success rate is around 97%, which contributes to the market's expansion. However, some limitations that could hinder the market growth include restricted use in those with severe osteoporosis and hypovolemic situations, as well as an elevated risk of compartment syndrome due to fluid and medication spilling into soft tissues.
Challenges- A number of issues could impede the global market for intraosseous infusion (IO) devices' expansion and broad acceptance. Accessibility may be restricted by the high cost of IO devices and related consumables, especially in healthcare settings with limited resources. Inadequate training for healthcare workers is another issue, which may result in inappropriate use or insufficient proficiency in emergency scenarios. Furthermore, the possibility of consequences including infection, tissue injury, or incorrect insertion can discourage medical professionals from employing IO devices instead of more conventional intravenous techniques. Regulatory obstacles and disparate national standards can further complicate the market, delaying the adoption and rollout of new goods.
Market Competitive Landscape
The Global Intraosseous Infusion Devices Market is moderately consolidated. Some of the market key players are Aero Healthcare, Becton Dickinson and Company, Biopsybell, Cardinal Health, Inc., Cook Medical Incorporated, PAVmed, PerSys Medical, Pyng Medical Corp., SAM Medical, Teleflex, Inc., Others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Product, By Route of Administration, By Technology, By End User.
|
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe. |
| Companies Covered | Aero Healthcare, Becton Dickinson and Company, Biopsybell, Cardinal Health, Inc., Cook Medical Incorporated, PAVmed, PerSys Medical, Pyng Medical Corp., SAM Medical, Teleflex, Inc., Others. |
COVID-19 Impact on Global Intraosseous Infusion Devices Market
The global market for intraosseous infusion (IO) devices was significantly impacted by the COVID-19 pandemic, which changed supply and demand. On the one hand, the pandemic's increased demand for quick and efficient medical care led to a boom in the use of IO devices, particularly in emergency and critical care settings where patient conditions or a shortage of available veins made traditional intravenous access more challenging. Further interest in IO devices as a practical alternative for urgent fluid and medicine delivery resulted from the pandemic's increased focus on making sure medical personnel were equipped to handle severe patients.
Key Target Audience:
- Hospitals and Healthcare Institutions
- Emergency Medical Services (EMS)
- Military and Defense Medical Units
- Trauma Centers and Critical Care Units
- Ambulatory Surgical Centers
- Government and Non-Governmental Organizations (NGOs)
- Medical Device Distributors and Suppliers
Our in-depth analysis of the Intraosseous Infusion Devices Market includes the following segments:
| By Product: | B.I.GFAST1EZ-IOFASTRIO NeedlesOthers |
| By Route of Administration: | SternumDistal & Proximal TibiaDistal FemurCalcaneusHead of Humerus |
| By Technology: | ManualAutomaticImpact DrivenPower Drill |
| By End User: | EMSHospitalsAmbulatory Surgical CentersCardiac Care Centers |
Key Topics Covered in the Report:
- Global Intraosseous Infusion Devices Market Size (FY’2024-FY’2033)
- Overview of Global Intraosseous Infusion Devices Market
- Segmentation of Global Intraosseous Infusion Devices Market By Product (B.I.G, FAST1, EZ-IO, FASTR, IO Needles, Others)
- Segmentation of Global Intraosseous Infusion Devices Market By Route of Administration (Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus, Head of Humerus)
- Segmentation of Global Intraosseous Infusion Devices Market By Technology (Manual, Automatic, Impact Driven, Power Drill)
- Segmentation of Global Intraosseous Infusion Devices Market By End User (EMS, Hospitals, Ambulatory Surgical Centers, Cardiac Care Centers)
- Statistical Snap of Global Intraosseous Infusion Devices Market
- Expansion Analysis of Global Intraosseous Infusion Devices Market
- Problems and Obstacles in Global Intraosseous Infusion Devices Market
- Competitive Landscape in the Global Intraosseous Infusion Devices Market
- Impact of COVID-19 and Demonetization on Global Intraosseous Infusion Devices Market
- Details on Current Investment in Global Intraosseous Infusion Devices Market
- Competitive Analysis of Global Intraosseous Infusion Devices Market
- Prominent Players in the Global Intraosseous Infusion Devices Market
- SWOT Analysis of Global Intraosseous Infusion Devices Market
- Global Intraosseous Infusion Devices Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Intraosseous Infusion Devices Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Intraosseous Infusion Devices Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Intraosseous Infusion Devices Market
7. Global Intraosseous Infusion Devices Market, By Product (USD Million) 2020-2033
7.1. Global Intraosseous Infusion Devices Market Size, Share and Forecast, By Type, 2020-2026
7.2. Global Intraosseous Infusion Devices Market Size, Share and Forecast, By Type, 2027-2033
7.3. B.I.G
7.4. FAST1
7.5. EZ-IO
7.6. FASTR
7.7. IO Needles
7.8. Others
8. Global Intraosseous Infusion Devices Market, By Route of Administration (USD Million) 2020-2033
8.1. Global Intraosseous Infusion Devices Market Size, Share and Forecast, By Route of Administration, 2020-2026
8.2. Global Intraosseous Infusion Devices Market Size, Share and Forecast, By Route of Administration, 2027-2033
8.3. Sternum
8.4. Distal & Proximal Tibia
8.5. Distal Femur
8.6. Calcaneus
8.7. Head of Humerus
9. Global Intraosseous Infusion Devices Market, By Technology (USD Million) 2020-2033
9.1. Global Intraosseous Infusion Devices Market Size, Share and Forecast, By Technology, 2020-2026
9.2. Global Intraosseous Infusion Devices Market Size, Share and Forecast, By Technology, 2027-2033
9.1. Manual
9.2. Automatic
9.3. Impact Driven
9.4. Power Drill
10. Global Intraosseous Infusion Devices Market, By End User (USD Million) 2020-2033
10.1. Global Intraosseous Infusion Devices Market Size, Share and Forecast, By End User, 2020-2026
10.2. Global Intraosseous Infusion Devices Market Size, Share and Forecast, By End User, 2027-2033
10.3. EMS
10.4. Hospitals
10.5. Ambulatory Surgical Centers
10.6. Cardiac Care Centers
11. Global Intraosseous Infusion Devices Market Forecast, 2020-2033 (USD Million)
11.1. Global Intraosseous Infusion Devices Market Size and Market Share
12. Global Intraosseous Infusion Devices Market, By Region, 2020-2033 (USD Million)
12.1. Global Intraosseous Infusion Devices Market Size and Market Share By Region (2020-2026)
12.2. Global Intraosseous Infusion Devices Market Size and Market Share By Region (2027-2033)
12.3. Asia-Pacific
12.3.1. Australia
12.3.2. China
12.3.3. India
12.3.4. Japan
12.3.5. South Korea
12.3.6. Rest of Asia-Pacific
12.4. Europe
12.4.1. France
12.4.2. Germany
12.4.3. Italy
12.4.4. Spain
12.4.5. United Kingdom
12.4.6. Rest of Europe
12.5. Middle East and Africa
12.5.1. Kingdom of Saudi Arabia
12.5.2. United Arab Emirates
12.5.3. Qatar
12.5.4. South Africa
12.5.5. Egypt
12.5.6. Morocco
12.5.7. Nigeria
12.5.8. Rest of Middle-East and Africa
12.6. North America
12.6.1. Canada
12.6.2. Mexico
12.6.3. United States
12.7. Latin America
12.7.1. Argentina
12.7.2. Brazil
12.7.3. Rest of Latin America
13. Company Profile
13.1. Aero Healthcare
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments
13.2. Becton Dickinson and Company
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments
13.3. Biopsybell
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments
13.4. Cardinal Health, Inc.
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments
13.5. Cook Medical Incorporated
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments
13.6. PAVmed
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments
13.7. PerSys Medical
13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary
13.7.4. Recent developments
13.8. Pyng Medical Corp.
13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary
13.8.4. Recent developments
13.9. SAM Medical
13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary
13.9.4. Recent developments
13.10. Teleflex, Inc.
13.10.1. Company details
13.10.2. Financial outlook
13.10.3. Product summary
13.10.4. Recent developments
13.11. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links